Thus, our data illustrate the crosstalk between FGF/FGFR and VEGF/VEGFR signaling pathways in GIST due to the ability of FGF2 to stimulate the production of VEGF-A and further activate the downstream VEGFR signaling cascade. The gene discussed is VEGFA; the disease is gastrointestinal stromal tumor.